Exitel Plus Tablets for Dogs
Exitel Plus Tablets for Dogs
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Exitel Plus Tablets for Dogs
Exitel Plus Tabletten für Hunde
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00847
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0242/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 24/07/2025
Summary of Product Characteristics
English (PDF)
Download Published on: 24/08/2025
German (PDF)
Published on: 24/07/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 18/08/2023
Updated on: 24/07/2025
Combined File of all Documents
English (PDF)
Download Published on: 24/08/2025